-
公开(公告)号:US20240124857A1
公开(公告)日:2024-04-18
申请号:US18277440
申请日:2022-02-18
IPC分类号: C12N9/16 , A61K35/745
CPC分类号: C12N9/16 , A61K35/745 , C12Y301/03002
摘要: Provided herein, inter alia, are compositions and methods for treating and/or preventing conditions associated with gut inflammation caused by dysbiosis via use of exogenously administered acid phosphatases or enzymes of the GDA1_CD39 superfamily (such as apyrases).
-
公开(公告)号:US20220008488A1
公开(公告)日:2022-01-13
申请号:US17240433
申请日:2021-04-26
发明人: SEBASTIEN GUERY , MARKUS LEHTINEN , SINIKKA ANNELI LATVALA , LIISA LEHTORANTA , BRYAN-JAMES Zabel , WESLEY WILLIAM MOROVIC , CHARLES BUDINOFF , SCOTT D. POWER
IPC分类号: A61K35/745 , A61K35/744 , A61P31/14
摘要: This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
-